Cost-effectiveness Analysis of Four Kinds of Oral Hypoglycemic Drugs in Treating Diabetes / 中国药房
China Pharmacy
;
(12)1991.
Article
in Chinese
| WPRIM
| ID: wpr-521967
ABSTRACT
OBJECTIVE:
To select a best therapeutic scheme for diabetes among four kinds of oral hypoglycemic drugsrepaglinide(Novonorm),glibenclamide,gliclazide and glipizide.METHODS:
According to the principle of pharmacoeconomics,using cost-effectiveness analysis(CEA),assessment and survey of the influencing factors(price,dosage)were carried out,at the same time,sensitive analysis was performed.RESULTS:
The best therapeutic scheme was Novonorm and the rest were gliclazide,glipizide and glibenclamide in sequence.CONCLUSION:
The result of sensitive analysis is in keeping with that of CEA,which indicates the credibility of CEA.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Health economic evaluation
Language:
Chinese
Journal:
China Pharmacy
Year:
1991
Type:
Article
Similar
MEDLINE
...
LILACS
LIS